Community pharmacies are being squeezed out of local markets, creating pharmacy deserts that raise costs, reduce access, and strain the healthcare system.
Michael Abrams, Numerof & Associates
Advertisement
Managing partner at Numerof & Associates.
Articles by Michael Abrams, Numerof & Associates
How can buyers maximize the value of their acquisitions?
A lack of access could shut out patients in need of maintenance drugs for complex conditions.
A new, market-driven model of drug development and commercialization is appearing*
Advertisement
Latest Updated Articles
- Bringing value to healthcare: practical steps for getting to a market-based model
Published: March 9th 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Designing Patient Hubs Purpose-Built for Cell and Gene Therapies
2
FTC–Express Scripts Settlement Targets PBM Rebates, Transparency, and Patient Drug Costs
3
Pharma Pulse: TrumpRx Takes Flight and Novo Nordisk’s Super Bowl Gambit
4
Lasix ONYU Gains Major Distributor Access Through Cardinal Health and Cencora
5